rosiglitazone has been researched along with Cerebral Hemorrhage in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Y; Wu, G | 1 |
| Jiao, Y; Ren, S; Wang, L; Wu, G | 1 |
| Hang, H; Ren, SY; Song, AJ; Wang, LK; Wu, GF | 1 |
| Luo, X; Wu, G; Wu, J | 1 |
| Hang, H; Liu, C; Mu, Q; Wang, L; Wu, G | 1 |
| Jiao, Y; Wang, F; Wang, L; Wu, G; Wu, J; Zhang, Y | 1 |
| Jiao, Y; Tang, Z; Wang, L; Wu, G; Wu, J; Zhou, H | 1 |
| Aronowski, J; Gonzales, N; Grotta, J; Zhao, X | 1 |
8 other study(ies) available for rosiglitazone and Cerebral Hemorrhage
| Article | Year |
|---|---|
Optimizing the Time Window of Minimally Invasive Stereotactic Surgery for Intracerebral Hemorrhage Evacuation Combined with Rosiglitazone Infusion Therapy in Rabbits.
Topics: Animals; Blood-Brain Barrier; Cerebral Hemorrhage; Disease Models, Animal; Glutamic Acid; Interleukin-1beta; Interleukin-6; Minimally Invasive Surgical Procedures; Nitric Oxide Synthase; PPAR gamma; Rabbits; RNA, Messenger; Rosiglitazone; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Water | 2022 |
PPARγ/RAD21 alleviates peripheral secondary brain injury in rat cerebral hemorrhage model through promoting M2 polarization of microglial cells.
Topics: Animals; Brain Injuries; Brain Neoplasms; Cerebral Hemorrhage; Interleukin-10; Microglia; PPAR gamma; Rats; Rosiglitazone; Thrombin; Tumor Necrosis Factor-alpha | 2023 |
Activating PPARγ Increases NQO1 and γ-GCS Expression via Nrf2 in Thrombin-activated Microglia.
Topics: Animals; Animals, Newborn; Cells, Cultured; Cerebral Hemorrhage; Disease Models, Animal; Female; Glutamate-Cysteine Ligase; Isothiocyanates; Male; Microglia; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; PPAR gamma; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sulfoxides; Thrombin; Tretinoin | 2020 |
PPARγ activation suppresses the expression of MMP9 by downregulating NF-κB post intracerebral hemorrhage.
Topics: Anilides; Animals; Cell Line; Cerebral Hemorrhage; Disease Models, Animal; Down-Regulation; Humans; Male; Matrix Metalloproteinase 9; Mice; NF-kappa B; Phenylenediamines; PPAR gamma; Rats; Rosiglitazone | 2021 |
Rosiglitazone pretreatment influences thrombin-induced phagocytosis by rat microglia via activating PPARγ and CD36.
Topics: Animals; Brain Injuries; CD36 Antigens; Cerebral Hemorrhage; Microglia; Neuroprotective Agents; Phagocytosis; PPAR gamma; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Thrombin | 2017 |
Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Hematoma; Hypoglycemic Agents; Infusions, Intraventricular; Male; Matrix Metalloproteinase 9; Minimally Invasive Surgical Procedures; Permeability; PPAR gamma; Rabbits; Random Allocation; Rosiglitazone; Thiazolidinediones | 2015 |
Minimally invasive surgery for ICH evacuation followed by rosiglitazone infusion therapy increased perihematomal PPARγ expression and improved neurological outcomes in rabbits.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Cerebral Hemorrhage; Disease Models, Animal; Fibrinolytic Agents; Gene Expression Regulation; Male; Minimally Invasive Surgical Procedures; Nervous System Diseases; Permeability; PPAR gamma; Rabbits; Rosiglitazone; Thiazolidinediones; Tomography Scanners, X-Ray Computed | 2016 |
Hematoma resolution as a therapeutic target: the role of microglia/macrophages.
Topics: Animals; Apoptosis; Catalase; CD36 Antigens; Cerebral Hemorrhage; Disease Models, Animal; Erythrocytes; Hematoma; Humans; Macrophages; Mice; Microglia; Phagocytosis; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |